IP Library Granted Patent US 8,466,311
Granted Patent B2
US 8,466,311 · App. 13/236,579 · Granted Jun 18, 2013

Neuroprotective compositions and methods

Inventors: Stuart A. Lipton (La Jolla, CA); Takumi Satoh (La Jolla, CA)
Assignee: Sanford-Burnham Medical Research Institute
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,466,311
App. No.
13/236,579
Granted
Jun 18, 2013
Kind
B2
Abstract

Neurite outgrowth-promoting prostaglandins (NEPPs) and other electrophilic compounds bind to Keap1, a negative regulator of the transcription factor Nrf2, and prevent Keap1-mediated inactivation of Nrf2 and, thus, enhance Nrf2 translocation into the nucleus of neuronal cells. Therefore, neuroprotective compositions and related methods are provided that employ such neuroprotective compounds, and prodrugs of such compounds, to cause dissociation of Nrf2 from a Keap1/Nrf2 complex.

Claims (11)

1. A compound, or pharmaceutically acceptable salt thereof, of Formula IV:

wherein:

X 24 , and X 27 are each independently H, OH, oxo, or Y; and X 21 , X 22 , X 23 , and X 25 are each null;

Y is B—C-D or C—B-D or C—B—C-D, any of which may be attached to a ring carbon to form a fused ring;

B is selected from the group consisting of null, carbonyl, carboxy, ether, sulfanyl, amino, —NHC(O)— and —C(O)NH—, any of which is optionally substituted;

C is selected from the group consisting of null, alkyl, cycloalkyl, alkenyl, cycloalkenyl, aryl, arylalkyl, and arylalkenyl, any of which is optionally substituted, and which may be attached to a ring carbon so as to form a fused ring; and

D is selected from the group consisting of null, carboxy, benzoic acid, hydroxybenzoic acid, SO 3 H, PO 3 , NO 3 , NO 2 , NO, amino, hydroxyl;

wherein X 26 is methyl; and

wherein B, and C are optionally substituted with one or more substituents independently selected from lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower heteroalkyl, lower heterocycloalkyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower perhaloalkyl, lower perhaloalkoxy, lower cycloalkyl, phenyl, aryl, aryloxy, lower alkoxy, lower haloalkoxy, oxo, lower acyloxy, carbonyl, carboxyl, lower alkylcarbonyl, lower carboxyester, lower carboxamido, cyano, hydrogen, halogen, hydroxy, amino, lower alkylamino, arylamino, amido, nitro, thiol, lower alkylthio, arylthio, lower alkylsulfinyl, lower alkylsulfonyl, arylsulfinyl, arylsulfonyl, arylthio, sulfonate, sulfonic acid, trisubstituted silyl, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 , CO 2 H, pyridinyl, thiophene, furanyl, lower carbamate, and lower urea.

2. The compound of claim 1 wherein C is an alkyl.

3. The compound of claim 1 wherein X 27 and X 24 are each independently methyl.

Assignments (1)
CONFIRMATORY LICENSE Recorded Feb 23, 2017
From: SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 041791/0099 →
Continuity (4)
Continuation 11974114 · Oct 10, 2007
Provisional Application 60850860 · Oct 10, 2006
Provisional Application 60850918 · Oct 10, 2006
Related Publication 20120296112A1 · Nov 22, 2012